Create, iterate, and publish HEOR, Medical Affairs, and RWE studies in a matter of days

Validate evidence using multiple data assets to ensure accuracy and increase confidence

Rapidly iterate through studies to ensure feasibility and relevance.

App screenshot on smartphone

Create novel, validated evidence to respond to medical questions and market trends in near-real time

Support patients and clinicians through the publication of novel studies to support clinical, regulatory, and reimbursement decisions.

Atropos Health’s products and services simplify and streamline study generation for HEOR, Medical Affairs and R&D

fast icon

HEOR studies

Run publication-grade end-to-end cost and outcomes studies with the support of Atropos’ clinicians, epidemiologists, and data scientists. 

effortless icon

Protocol development & publication support

Never miss a publication deadline again with streamlined, technology-enabled evidence generation and publication.

Cost of care analysis

Quickly analyze patient costs and outcomes to respond to payor, formulary, and regulatory inquiries.

RWE automation

Novel technology enables industry-leading speed in generating high-quality RWE evidence on all RWD data sources. 

Generative AI tools for MSL deployment

Accelerate response to medical inquiries (MIRFs) through novel, purpose-built generative AI tools.

Our Results in Numbers

5-10X

Study and insight output in 10% of the time.

$21M

ROI savings from reduced outsourced service and data costs.

48hr

SLA on Real World Evidence Studies.

What life science leaders say about Atropos Health

Read more about what our customers and partners have to say.

Academic Medical Center: Deputy Director
“I am interested in current survival outcomes for patients with recurrent glioblastoma, both all patients and those that undergo surgical resection. This is extremely impressive and interesting, especially since I wasn’t sure...
Deputy Director, T Cell Therapeutics Research Laboratory, Professor, Departments of Hematology & Hematopoietic Cell Transplantation and Immuno-Oncology
Academic Medical Center
“I am interested in current survival outcomes for patients with recurrent glioblastoma, both all patients and those that undergo surgical resection. This is extremely impressive and interesting, especially since I wasn’t sure there would be sufficient data to look at with and without resection! Very interesting to see about CAR-Ts and checkpoint inhibitors as well!"
Academic Medical Center: Deputy Director
Deputy Director, T Cell Therapeutics Research Laboratory, Professor, Departments of Hematology & Hematopoietic Cell Transplantation and Immuno-Oncology
Academic Medical Center
Pharma Client: Global Evidence Lead
"I’m looking for a balance of broad data access and the skills to analyze it. This collaboration offers both."
Global Evidence Lead
Pharma Client
"I’m looking for a balance of broad data access and the skills to analyze it. This collaboration offers both."
Pharma Client: Global Evidence Lead
Global Evidence Lead
Pharma Client
Pharma Client: Director of RWE
“The Evidence Network is changing the way our industry thinks and buys data. The fact that you can match the right data to questions is a game-changer.”
Director of RWE
Pharma Client
“The Evidence Network is changing the way our industry thinks and buys data. The fact that you can match the right data to questions is a game-changer.”
Pharma Client: Director of RWE
Director of RWE
Pharma Client

The Atropos Evidence Network has the Real World Data (RWD) available on day 1 to answer your questions

Learn more about the Atropos Evidence Network.

Validate evidence using multiple data assets to ensure accuracy and increase confidence with Atropos Health